OHK Medical Devices manufactures HemaClear, a single-use, sterile exsanguinating tourniquet device designed for use in bloodless orthopedic surgery.
Inbar, who previously served as vice president of sales, was instrumental in strong revenue growth of Hemaclear over the past two years.
OHK Medical Devices CEO Omer Inbar said he is thrilled to lead the new team through the next phase of growth.
"This is an exciting time for the company as we continue to grow our flagship HemaClear product as the tourniquet of choice by hospitals worldwide, and begin to introduce new generation HemaClear products and additional technologies to the market," Inbar added.
